Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
DeLauro targets ortho ads: Rep. Rosa DeLauro, D-Conn., says she may introduce a bill banning direct-to-consumer advertising for hip and knee implants for three years post-FDA approval. She has previously sponsored similar, unsuccessful legislation on drugs alone, but at an Oct. 3 speech at George Washington University, she cited a "new concern" with hip and knee ads "giving no indication of the potential complications and side effects from the major surgery they require." DeLauro, chair of the House appropriations panel that oversees FDA's budget, has noted that her own upcoming hip replacement surgery drew her to the issue. Her speech was mainly about a proposal to create a distinct Food Safety Administration and rename the rest of FDA the Federal Drug and Device Administration
You may also be interested in...
Senate Explores Restrictions On Direct-To-Consumer Device Ads
Senate Special Committee on Aging Chairman Herb Kohl, D-Wis., is considering legislation to restrict direct-to-consumer advertising of medical devices
Senate Explores Restrictions On Direct-To-Consumer Device Ads
Senate Special Committee on Aging Chairman Herb Kohl, D-Wis., is considering legislation to restrict direct-to-consumer advertising of medical devices
Device Firms Under Pressure To Add More Warnings To DTC Ads
Public pressure is increasing on device firms, especially orthopedic implant manufacturers, to include more detailed risk information about their products in direct-to-consumer broadcast advertisements